About: Endocrine therapy use among elderly hormone receptor-positive breast cancer patients enrolled in Medicare Part D

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Endocrine therapy use among elderly hormone receptor-positive breast cancer patients enrolled in Medicare Part D Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article (publication date: 13 December 2011)

Attributes	Values
rdf:type	Item
description	wissenschaftlicher Artikel (de) artículu científicu espublizáu en 2011 (ast) vědecký článek publikovaný v roce 2011 (cs) 2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած (hyw) 2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված (hy) наукова стаття, опублікована в грудні 2011 (uk) wetenschappelijk artikel (gepubliceerd op 2011/12/13) (nl) vedecký článok (publikovaný 2011/12/13) (sk) مقالة علمية (نشرت في 13-12-2011) (ar) article scientifique publié en 2011 (fr) scientific article (publication date: 13 December 2011) (en)
publication date	wds:Q28657951-CA659F40-7FCE-44A8-8E66-EBF3DBBF6EFF
publication date	2011-12-13 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q28657951-33A337F7-106D-4BFE-9674-3C63ED414D8C
language of work or name	English
cites work	wds:Q28657951-05E1102D-9325-4583-ADF0-AD89414C2983 wds:Q28657951-07144FB3-2C73-4499-B4D5-E24AE168E06E wds:Q28657951-07D3D1EA-44D7-471F-B4CA-FF19437EAC45 wds:Q28657951-0B13F82F-D277-47B3-9F27-B154B99D8730 wds:Q28657951-0F7A9A75-074E-4A7C-A5A1-E722D3FF7C80 wds:Q28657951-13764BDB-1D57-4206-A1E5-B36FBBAA181C wds:Q28657951-1ACD02AC-0174-4E51-A31F-BC1D38B2E750 wds:Q28657951-2BA00802-041C-4836-A0A7-BDC8885A8D50 wds:Q28657951-30EC3E2A-E98F-471E-82C3-E0C7C9EF3BEB wds:Q28657951-324C42C0-1B92-4E58-815F-C7521CF6AC30 wds:Q28657951-78CB8852-9A61-41ED-AA86-A0372FB7EB57 wds:Q28657951-7B846F30-4A3B-44C1-B07B-AF1E0882480C wds:Q28657951-89DE95F6-D60C-4592-91D1-473312B29219 wds:Q28657951-A31DE875-4798-4937-9D98-FF8459C7128B wds:Q28657951-A5B181FB-D720-4E71-9461-80ACE1A3B281 wds:Q28657951-AAF77FCD-A099-4037-9367-A5C8D0DF731B wds:Q28657951-B0C67624-0558-4D03-9E59-073F01934B42 wds:Q28657951-B8B494D9-CDD0-4407-8719-0DFC99E5A3B5 wds:Q28657951-BA9DC586-4EF2-457F-820C-2BB523BDD79A wds:Q28657951-CEF61569-45D3-4C25-A15C-5F539EB6E66A wds:Q28657951-CF955BAD-836E-48D9-957B-D2A69C70B121 wds:Q28657951-D38A81A9-24D0-46FD-AE25-CBF1E4CA3543 wds:Q28657951-D93432F4-003F-48BE-B173-95C8024FB75E wds:Q28657951-EEC25C56-631F-4A88-8DF2-B843C296305D wds:Q28657951-F3FFF5D4-E7E5-4043-8418-4B25D323274B
cites work	A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer At Pitney Bowes, value-based insurance design cut copayments and increased drug adherence Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Adherence to tamoxifen over the five-year course Adjuvant hormonal therapy use among insured, low-income women with breast cancer Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population Medicare beneficiaries' knowledge of and choices regarding Part D, 2005 to the present Copayment reductions generate greater medication adherence in targeted patients Changes in drug use and out-of-pocket costs associated with Medicare Part D implementation: a systematic review Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients Risk adjustment of Medicare capitation payments using the CMS-HCC model Adherence to endocrine therapy for breast cancer Prescription drug cost sharing: associations with medication and medical utilization and spending and health. Improving compliance and persistence to adjuvant tamoxifen and aromatase inhibitor therapy Adverse selection in the Medicare prescription drug program Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer Cost minimization of medicare part D prescription drug plan expenditures Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000. Predictors and temporal trends of adjuvant aromatase inhibitor use in breast cancer Patient centered experiences in breast cancer: predicting long-term adherence to tamoxifen use. Benefits and Consequences for the Poor and the Disabled Diffusion of aromatase inhibitors for breast cancer therapy between 1996 and 2003 in the Cancer Research Network
author name string	wds:Q28657951-5C687B42-08F7-4D09-9460-6688AF58BC35 wds:Q28657951-6151F5F1-8E5F-4B2C-BABD-F29D209CE7DA wds:Q28657951-807CD3E9-DE61-43AA-B5F4-9A1214855C78 wds:Q28657951-878E8502-8BBC-47BE-8C53-E4DB250F082A
OpenCitations bibliographic resource ID	wds:Q28657951-E89911F7-B72F-4582-9739-5D7988638951
OpenCitations bibliographic resource ID	https://w3id.org/oc/corpus/br/3236513
author name string	Gerald F Riley Joan L Warren Linda C Harlan Steven A Blackwell
OpenCitations bibliographic resource ID	3236513
rdfs:label	Endocrine therapy use among elderly hormone receptor-positive breast cancer patients enrolled in Medicare Part D (en) Endocrine therapy use among elderly hormone receptor-positive breast cancer patients enrolled in Medicare Part D (nl) Endocrine therapy use among elderly hormone receptor-positive breast cancer patients enrolled in Medicare Part D (ast)
skos:prefLabel	Endocrine therapy use among elderly hormone receptor-positive breast cancer patients enrolled in Medicare Part D (en) Endocrine therapy use among elderly hormone receptor-positive breast cancer patients enrolled in Medicare Part D (nl) Endocrine therapy use among elderly hormone receptor-positive breast cancer patients enrolled in Medicare Part D (ast)
name	Endocrine therapy use among elderly hormone receptor-positive breast cancer patients enrolled in Medicare Part D (en) Endocrine therapy use among elderly hormone receptor-positive breast cancer patients enrolled in Medicare Part D (nl) Endocrine therapy use among elderly hormone receptor-positive breast cancer patients enrolled in Medicare Part D (ast)
title	wds:Q28657951-543D2DC7-B1EB-4EA5-B3B5-74EBA1E30CD3
title	Endocrine therapy use among elderly hormone receptor-positive breast cancer patients enrolled in Medicare Part D (en)
page(s)	wds:Q28657951-BE4504E4-CE26-4B77-A790-A96FF3B36542
page(s)	E1-E26
instance of	wds:Q28657951-80032763-BF71-4974-9F85-B912549DE63A
instance of	scholarly article
main subject	wds:Q28657951-32BEACFA-DC38-4823-86DF-D07B6ABE0FD3 wds:Q28657951-A2C989A3-2868-43A5-9072-B07AD23B59DC wds:Q28657951-D58C5962-605C-4EFE-AFB6-C9353E209DE7
main subject	Medicare breast cancer Patients
PubMed ID	wds:Q28657951-A44B443D-293A-49CD-8608-54FA97C24CAF
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22340780

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software